Kazumasa Takenaka - Concepedia

Author

Kazumasa Takenaka

Kyoto University

Also Known As

K TAKENAKA, K Takenaka, K. Takenaka, Kayo TAKENAKA, Kazuki Takenaka, Kazumasa Takenaka, Kenji Takenaka

114

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Kyoto University Hyogo Medical University Kyoto University Hospital St. Jude Children's Research Hospital Kyushu University

About

Kazumasa Takenaka is an author at Kyoto University specializing in medicine, lung cancer, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	22	781
2	Engineering	2	2	49
3	Health Sciences	2	2	43
4	Biochemistry	2	2	40
5	Anesthesia	1	1	33

Kazumasa Takenaka

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Transporter-Mediated Protection against Thiopurine-Induced Hematopoietic Toxicity Partha Krishnamurthy, Matthias Schwab, Kazumasa Takenaka, Cancer Research	2008	140
Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer Kazumasa Takenaka, Shinya Ishikawa, Yozo Kawano, European Journal of Cancer Tumor BiologyMedicinePathologyBronchial NeoplasmCancer Biology	2004	104
Substrate Overlap between Mrp4 and Abcg2/Bcrp Affects Purine Analogue Drug Cytotoxicity and Tissue Distribution Kazumasa Takenaka, George L. Scheffer, Masashi Adachi, Cancer Research	2007	100
Matrix Metalloproteinase-2 Status in Stromal Fibroblasts, Not in Tumor Cells, Is a Significant Prognostic Factor in Non–Small-Cell Lung Cancer Shinya Ishikawa, Kazumasa Takenaka, Kazuhiro Yanagihara, Clinical Cancer Research	2004	92
Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients E. Ogawa, Kazumasa Takenaka, Kazuhiro Yanagihara, British Journal of Cancer	2004	83
Systemic inflammatory response syndrome and surgical stress in thoracic surgery Kazumasa Takenaka, Eiji Ogawa, Hiromi Wada, Journal of Critical Care InflammationSurgical StressSepsisThoracic SurgerySurgery	2006	75
Perimembrane Aurora-A Expression is a Significant Prognostic Factor in Correlation with Proliferative Activity in Non-Small-Cell Lung Cancer (NSCLC) Eiji Ogawa, Kazumasa Takenaka, Hiromichi Katakura, Annals of Surgical Oncology	2007	60
Impact of KRAS and EGFR Gene Mutations on Recurrence and Survival in Patients with Surgically Resected Lung Adenocarcinomas Makoto Sonobe, Masashi Kobayashi, Masashi Ishikawa, Annals of Surgical Oncology Surgical OncologyMedicineCancer RecurrencePathologyEgfr Gene Mutations	2011	58
Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer Eri Kawata, Eishi Ashihara, Shinya Kimura, Molecular Cancer Therapeutics	2008	58
Characterization of recombinant Xenopus MAP kinase kinases mutated at potential phosphorylation sites. Yukiko Gotoh, Shinji Matsuda, Kazumasa Takenaka, PubMed	1994	57

Page 1